Global Gastrointestinal Stromal Tumor (GIST) Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Gastrointestinal Stromal Tumor (GIST) Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Gastrointestinal Stromal Tumor (GIST) Drug by Country/Region, 2017, 2022 & 2028

2.2 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Type

2.2.1 Amcasertib

2.2.2 Anagrelide hydrochloride CR

2.2.3 APG-1351

2.2.4 Binimetinib

2.2.5 Others

2.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type

2.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sale Price by Type (2017-2022)

2.4 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Application

2.4.1 Clinic

2.4.2 Hospital

2.4.3 Others

2.5 Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application

2.5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sale Price by Application (2017-2022)

3 Global Gastrointestinal Stromal Tumor (GIST) Drug by Company

3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Breakdown Data by Company

3.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Sales by Company (2020-2022)

3.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Company (2020-2022)

3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Company (2020-2022)

3.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Company (2020-2022)

3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sale Price by Company

3.4 Key Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Product Location Distribution

3.4.2 Players Gastrointestinal Stromal Tumor (GIST) Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Gastrointestinal Stromal Tumor (GIST) Drug by Geographic Region

4.1 World Historic Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Revenue by Geographic Region

4.2 World Historic Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Revenue by Country/Region

4.3 Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth

4.4 APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth

4.5 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth

4.6 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth

5 Americas

5.1 Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country

5.1.1 Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2022)

5.1.2 Americas Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2022)

5.2 Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type

5.3 Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region

6.1.1 APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2017-2022)

6.1.2 APAC Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2017-2022)

6.2 APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type

6.3 APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug by Country

7.1.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2022)

7.1.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2022)

7.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type

7.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug by Country

8.1.1 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type

8.3 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Gastrointestinal Stromal Tumor (GIST) Drug

10.3 Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug

10.4 Industry Chain Structure of Gastrointestinal Stromal Tumor (GIST) Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Gastrointestinal Stromal Tumor (GIST) Drug Distributors

11.3 Gastrointestinal Stromal Tumor (GIST) Drug Customer

12 World Forecast Review for Gastrointestinal Stromal Tumor (GIST) Drug by Geographic Region

12.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Region

12.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecast by Region (2023-2028)

12.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecast by Type

12.7 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecast by Application

13 Key Players Analysis

13.1 Ariad Pharmaceuticals, Inc.

13.1.1 Ariad Pharmaceuticals, Inc. Company Information

13.1.2 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

13.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Ariad Pharmaceuticals, Inc. Main Business Overview

13.1.5 Ariad Pharmaceuticals, Inc. Latest Developments

13.2 Arog Pharmaceuticals, Inc.

13.2.1 Arog Pharmaceuticals, Inc. Company Information

13.2.2 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

13.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Arog Pharmaceuticals, Inc. Main Business Overview

13.2.5 Arog Pharmaceuticals, Inc. Latest Developments

13.3 Array BioPharma Inc.

13.3.1 Array BioPharma Inc. Company Information

13.3.2 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

13.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Array BioPharma Inc. Main Business Overview

13.3.5 Array BioPharma Inc. Latest Developments

13.4 Astex Pharmaceuticals, Inc.

13.4.1 Astex Pharmaceuticals, Inc. Company Information

13.4.2 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

13.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Astex Pharmaceuticals, Inc. Main Business Overview

13.4.5 Astex Pharmaceuticals, Inc. Latest Developments

13.5 Blueprint Medicines Corporation

13.5.1 Blueprint Medicines Corporation Company Information

13.5.2 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

13.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Blueprint Medicines Corporation Main Business Overview

13.5.5 Blueprint Medicines Corporation Latest Developments

13.6 Boston Biomedical, Inc.

13.6.1 Boston Biomedical, Inc. Company Information

13.6.2 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

13.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Boston Biomedical, Inc. Main Business Overview

13.6.5 Boston Biomedical, Inc. Latest Developments

13.7 Calithera Biosciences, Inc.

13.7.1 Calithera Biosciences, Inc. Company Information

13.7.2 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

13.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Calithera Biosciences, Inc. Main Business Overview

13.7.5 Calithera Biosciences, Inc. Latest Developments

13.8 Chipscreen Biosciences Ltd

13.8.1 Chipscreen Biosciences Ltd Company Information

13.8.2 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

13.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Chipscreen Biosciences Ltd Main Business Overview

13.8.5 Chipscreen Biosciences Ltd Latest Developments

13.9 Deciphera Pharmaceuticals, LLC

13.9.1 Deciphera Pharmaceuticals, LLC Company Information

13.9.2 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

13.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Deciphera Pharmaceuticals, LLC Main Business Overview

13.9.5 Deciphera Pharmaceuticals, LLC Latest Developments

13.10 F. Hoffmann-La Roche Ltd.

13.10.1 F. Hoffmann-La Roche Ltd. Company Information

13.10.2 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

13.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 F. Hoffmann-La Roche Ltd. Main Business Overview

13.10.5 F. Hoffmann-La Roche Ltd. Latest Developments

13.11 Horizon Pharma Plc

13.11.1 Horizon Pharma Plc Company Information

13.11.2 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

13.11.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Horizon Pharma Plc Main Business Overview

13.11.5 Horizon Pharma Plc Latest Developments

13.12 Immunicum AB

13.12.1 Immunicum AB Company Information

13.12.2 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

13.12.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Immunicum AB Main Business Overview

13.12.5 Immunicum AB Latest Developments

13.13 Jiangsu Hengrui Medicine Co., Ltd.

13.13.1 Jiangsu Hengrui Medicine Co., Ltd. Company Information

13.13.2 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

13.13.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Jiangsu Hengrui Medicine Co., Ltd. Main Business Overview

13.13.5 Jiangsu Hengrui Medicine Co., Ltd. Latest Developments

13.14 Kolltan Pharmaceuticals, Inc.

13.14.1 Kolltan Pharmaceuticals, Inc. Company Information

13.14.2 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

13.14.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Kolltan Pharmaceuticals, Inc. Main Business Overview

13.14.5 Kolltan Pharmaceuticals, Inc. Latest Developments

13.15 Natco Pharma Limited

13.15.1 Natco Pharma Limited Company Information

13.15.2 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

13.15.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Natco Pharma Limited Main Business Overview

13.15.5 Natco Pharma Limited Latest Developments

13.16 Nerviano Medical Sciences S.r.l.

13.16.1 Nerviano Medical Sciences S.r.l. Company Information

13.16.2 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

13.16.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Nerviano Medical Sciences S.r.l. Main Business Overview

13.16.5 Nerviano Medical Sciences S.r.l. Latest Developments

13.17 Novartis AG

13.17.1 Novartis AG Company Information

13.17.2 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

13.17.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Novartis AG Main Business Overview

13.17.5 Novartis AG Latest Developments

13.18 Omeros Corporation

13.18.1 Omeros Corporation Company Information

13.18.2 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

13.18.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Omeros Corporation Main Business Overview

13.18.5 Omeros Corporation Latest Developments

14 Research Findings and Conclusion

Table 1. Gastrointestinal Stromal Tumor (GIST) Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Gastrointestinal Stromal Tumor (GIST) Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Amcasertib

Table 4. Major Players of Anagrelide hydrochloride CR

Table 5. Major Players of APG-1351

Table 6. Major Players of Binimetinib

Table 7. Major Players of Others

Table 8. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2022) & (K Pcs)

Table 9. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2022)

Table 10. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2017-2022) & ($ million)

Table 11. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2017-2022)

Table 12. Global Gastrointestinal Stromal Tumor (GIST) Drug Sale Price by Type (2017-2022) & (USD/Pcs)

Table 13. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2022) & (K Pcs)

Table 14. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2022)

Table 15. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2017-2022)

Table 16. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application (2017-2022)

Table 17. Global Gastrointestinal Stromal Tumor (GIST) Drug Sale Price by Application (2017-2022) & (USD/Pcs)

Table 18. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Company (2020-2022) & (K Pcs)

Table 19. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Company (2020-2022)

Table 20. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Company (2020-2022)

Table 22. Global Gastrointestinal Stromal Tumor (GIST) Drug Sale Price by Company (2020-2022) & (USD/Pcs)

Table 23. Key Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Producing Area Distribution and Sales Area

Table 24. Players Gastrointestinal Stromal Tumor (GIST) Drug Products Offered

Table 25. Gastrointestinal Stromal Tumor (GIST) Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Geographic Region (2017-2022) & (K Pcs)

Table 29. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share Geographic Region (2017-2022)

Table 30. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country/Region (2017-2022) & (K Pcs)

Table 33. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country/Region (2017-2022)

Table 34. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2022) & (K Pcs)

Table 37. Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2017-2022)

Table 38. Americas Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country (2017-2022)

Table 40. Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2022) & (K Pcs)

Table 41. Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2022)

Table 42. Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2022) & (K Pcs)

Table 43. Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2022)

Table 44. APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2017-2022) & (K Pcs)

Table 45. APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2017-2022)

Table 46. APAC Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region (2017-2022)

Table 48. APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2022) & (K Pcs)

Table 49. APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2022)

Table 50. APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2022) & (K Pcs)

Table 51. APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2022)

Table 52. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2022) & (K Pcs)

Table 53. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2017-2022)

Table 54. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country (2017-2022)

Table 56. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2022) & (K Pcs)

Table 57. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2022)

Table 58. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2022) & (K Pcs)

Table 59. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2022) & (K Pcs)

Table 61. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Gastrointestinal Stromal Tumor (GIST) Drug

Table 69. Key Market Challenges & Risks of Gastrointestinal Stromal Tumor (GIST) Drug

Table 70. Key Industry Trends of Gastrointestinal Stromal Tumor (GIST) Drug

Table 71. Gastrointestinal Stromal Tumor (GIST) Drug Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Gastrointestinal Stromal Tumor (GIST) Drug Distributors List

Table 74. Gastrointestinal Stromal Tumor (GIST) Drug Customer List

Table 75. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 76. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Forecast by Region

Table 77. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 80. Americas Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 82. APAC Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Type (2023-2028) & (K Pcs)

Table 88. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Application (2023-2028) & (K Pcs)

Table 92. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share Forecast by Application (2023-2028)

Table 95. Ariad Pharmaceuticals, Inc. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors

Table 96. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

Table 97. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 98. Ariad Pharmaceuticals, Inc. Main Business

Table 99. Ariad Pharmaceuticals, Inc. Latest Developments

Table 100. Arog Pharmaceuticals, Inc. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors

Table 101. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

Table 102. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. Arog Pharmaceuticals, Inc. Main Business

Table 104. Arog Pharmaceuticals, Inc. Latest Developments

Table 105. Array BioPharma Inc. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors

Table 106. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

Table 107. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 108. Array BioPharma Inc. Main Business

Table 109. Array BioPharma Inc. Latest Developments

Table 110. Astex Pharmaceuticals, Inc. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors

Table 111. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

Table 112. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 113. Astex Pharmaceuticals, Inc. Main Business

Table 114. Astex Pharmaceuticals, Inc. Latest Developments

Table 115. Blueprint Medicines Corporation Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors

Table 116. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

Table 117. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 118. Blueprint Medicines Corporation Main Business

Table 119. Blueprint Medicines Corporation Latest Developments

Table 120. Boston Biomedical, Inc. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors

Table 121. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

Table 122. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 123. Boston Biomedical, Inc. Main Business

Table 124. Boston Biomedical, Inc. Latest Developments

Table 125. Calithera Biosciences, Inc. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors

Table 126. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

Table 127. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 128. Calithera Biosciences, Inc. Main Business

Table 129. Calithera Biosciences, Inc. Latest Developments

Table 130. Chipscreen Biosciences Ltd Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors

Table 131. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

Table 132. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 133. Chipscreen Biosciences Ltd Main Business

Table 134. Chipscreen Biosciences Ltd Latest Developments

Table 135. Deciphera Pharmaceuticals, LLC Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors

Table 136. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

Table 137. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 138. Deciphera Pharmaceuticals, LLC Main Business

Table 139. Deciphera Pharmaceuticals, LLC Latest Developments

Table 140. F. Hoffmann-La Roche Ltd. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors

Table 141. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

Table 142. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 143. F. Hoffmann-La Roche Ltd. Main Business

Table 144. F. Hoffmann-La Roche Ltd. Latest Developments

Table 145. Horizon Pharma Plc Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors

Table 146. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

Table 147. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 148. Horizon Pharma Plc Main Business

Table 149. Horizon Pharma Plc Latest Developments

Table 150. Immunicum AB Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors

Table 151. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

Table 152. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 153. Immunicum AB Main Business

Table 154. Immunicum AB Latest Developments

Table 155. Jiangsu Hengrui Medicine Co., Ltd. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors

Table 156. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

Table 157. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 158. Jiangsu Hengrui Medicine Co., Ltd. Main Business

Table 159. Jiangsu Hengrui Medicine Co., Ltd. Latest Developments

Table 160. Kolltan Pharmaceuticals, Inc. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors

Table 161. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

Table 162. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 163. Kolltan Pharmaceuticals, Inc. Main Business

Table 164. Kolltan Pharmaceuticals, Inc. Latest Developments

Table 165. Natco Pharma Limited Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors

Table 166. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

Table 167. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 168. Natco Pharma Limited Main Business

Table 169. Natco Pharma Limited Latest Developments

Table 170. Nerviano Medical Sciences S.r.l. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors

Table 171. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

Table 172. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 173. Nerviano Medical Sciences S.r.l. Main Business

Table 174. Nerviano Medical Sciences S.r.l. Latest Developments

Table 175. Novartis AG Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors

Table 176. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

Table 177. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 178. Novartis AG Main Business

Table 179. Novartis AG Latest Developments

Table 180. Omeros Corporation Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors

Table 181. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Offered

Table 182. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 183. Omeros Corporation Main Business

Table 184. Omeros Corporation Latest Developments

List of Figures

Figure 1. Picture of Gastrointestinal Stromal Tumor (GIST) Drug

Figure 2. Gastrointestinal Stromal Tumor (GIST) Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Amcasertib

Figure 10. Product Picture of Anagrelide hydrochloride CR

Figure 11. Product Picture of APG-1351

Figure 12. Product Picture of Binimetinib

Figure 13. Product Picture of Others

Figure 14. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type in 2021

Figure 15. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2017-2022)

Figure 16. Gastrointestinal Stromal Tumor (GIST) Drug Consumed in Clinic

Figure 17. Global Gastrointestinal Stromal Tumor (GIST) Drug Market: Clinic (2017-2022) & (K Pcs)

Figure 18. Gastrointestinal Stromal Tumor (GIST) Drug Consumed in Hospital

Figure 19. Global Gastrointestinal Stromal Tumor (GIST) Drug Market: Hospital (2017-2022) & (K Pcs)

Figure 20. Gastrointestinal Stromal Tumor (GIST) Drug Consumed in Others

Figure 21. Global Gastrointestinal Stromal Tumor (GIST) Drug Market: Others (2017-2022) & (K Pcs)

Figure 22. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2022)

Figure 23. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application in 2021

Figure 24. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Company in 2021

Figure 26. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Geographic Region in 2021

Figure 28. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2017-2022)

Figure 29. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country/Region in 2021

Figure 30. Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales 2017-2022 (K Pcs)

Figure 31. Americas Gastrointestinal Stromal Tumor (GIST) Drug Revenue 2017-2022 ($ Millions)

Figure 32. APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales 2017-2022 (K Pcs)

Figure 33. APAC Gastrointestinal Stromal Tumor (GIST) Drug Revenue 2017-2022 ($ Millions)

Figure 34. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales 2017-2022 (K Pcs)

Figure 35. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales 2017-2022 (K Pcs)

Figure 37. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue 2017-2022 ($ Millions)

Figure 38. Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country in 2021

Figure 39. Americas Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country in 2021

Figure 40. United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region in 2021

Figure 45. APAC Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Regions in 2021

Figure 46. China Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country in 2021

Figure 53. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country in 2021

Figure 54. Germany Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country in 2021

Figure 61. Egypt Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Gastrointestinal Stromal Tumor (GIST) Drug in 2021

Figure 67. Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug

Figure 68. Industry Chain Structure of Gastrointestinal Stromal Tumor (GIST) Drug

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles